488 related articles for article (PubMed ID: 15468596)
1. HIV-1-specific RNA interference.
Boden D; Pusch O; Ramratnam B
Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
[TBL] [Abstract][Full Text] [Related]
2. RNA interference as an antiviral approach: targeting HIV-1.
Berkhout B
Curr Opin Mol Ther; 2004 Apr; 6(2):141-5. PubMed ID: 15195925
[TBL] [Abstract][Full Text] [Related]
3. [RNA interference and its application in inhibiting HIV-1 infection].
Wei L; Liu X; Cao C
Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):516-9. PubMed ID: 16176084
[TBL] [Abstract][Full Text] [Related]
4. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
ter Brake O; Konstantinova P; Ceylan M; Berkhout B
Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
[TBL] [Abstract][Full Text] [Related]
5. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
6. Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape.
Leonard JN; Schaffer DV
J Virol; 2005 Feb; 79(3):1645-54. PubMed ID: 15650190
[TBL] [Abstract][Full Text] [Related]
7. Control of HIV-1 replication by RNA interference.
Lee NS; Rossi JJ
Virus Res; 2004 Jun; 102(1):53-8. PubMed ID: 15068880
[TBL] [Abstract][Full Text] [Related]
8. RNAi-inducing lentiviral vectors for anti-HIV-1 gene therapy.
Liu YP; Westerink JT; ter Brake O; Berkhout B
Methods Mol Biol; 2011; 721():293-311. PubMed ID: 21431693
[TBL] [Abstract][Full Text] [Related]
9. Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression.
Butticaz C; Ciuffi A; Muñoz M; Thomas J; Bridge A; Pebernard S; Iggo R; Meylan P; Telenti A
Antivir Ther; 2003 Oct; 8(5):373-7. PubMed ID: 14640383
[TBL] [Abstract][Full Text] [Related]
10. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
Takahashi Y; Nishikawa M; Takakura Y
Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
[TBL] [Abstract][Full Text] [Related]
12. The future of HIV infection: gene therapy and RNA interference.
Delgado R; Regueiro BJ
Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():68-83. PubMed ID: 16373006
[TBL] [Abstract][Full Text] [Related]
13. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells.
Park WS; Hayafune M; Miyano-Kurosaki N; Takaku H
Gene Ther; 2003 Nov; 10(24):2046-50. PubMed ID: 14566364
[TBL] [Abstract][Full Text] [Related]
14. Overcoming HIV-1 resistance to RNA interference.
Boden D; Pusch O; Ramratnam B
Front Biosci; 2007 May; 12():3104-16. PubMed ID: 17485285
[TBL] [Abstract][Full Text] [Related]
15. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
Anderson J; Akkina R
Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
[TBL] [Abstract][Full Text] [Related]
16. Delivering antiviral siRNA into human T-cells: New approaches in RNAi-based HIV therapy.
Ban HS; Lee SK; Kumar P
IDrugs; 2009 Dec; 12(12):774-8. PubMed ID: 19943220
[TBL] [Abstract][Full Text] [Related]
17. RNAi in functional genomics.
Scherr M; Eder M
Curr Opin Mol Ther; 2004 Apr; 6(2):129-35. PubMed ID: 15195923
[TBL] [Abstract][Full Text] [Related]
18. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
Akhtar S; Benter I
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
[TBL] [Abstract][Full Text] [Related]
19. Suppression of HIV replication using RNA interference against HIV-1 integrase.
Lau TS; Li Y; Kameoka M; Ng TB; Wan DC
FEBS Lett; 2007 Jul; 581(17):3253-9. PubMed ID: 17592732
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
Chang LJ; Liu X; He J
Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
